Kinnate Biopharma Inc.
Inhibitors of RAF kinases

Abstract:

Provided herein are heteroaryl inhibitors of receptor tyrosine kinase effector (RAF), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of disease.